miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• MicroRNAs (miRNAs) are key regulators of T cell immune responses.
• Identifying miRNAs that control T cell differentiation is crucial for immunotherapy.
• Dysregulation of T cell function contributes to cancer progression.

Purpose of the Study:

• To identify microRNAs regulating T cell differentiation.
• To investigate the role of miR-143 in CD8+ T cell differentiation and function.
• To explore miR-143's therapeutic potential in esophageal cancer.

Main Methods:

• Overexpression and inhibition of miR-143 in CD8+ T cells from healthy donors.
• Analysis of T cell differentiation, apoptosis, and cytokine secretion.
• Assessment of CAR T cell-mediated anti-tumor activity against esophageal cancer cells.
• Identification of miR-143 target genes (Glut-1) and upstream regulators (IDO).
• Analysis of miR-143 and Tcm cell levels in patient tumor tissues.

Main Results:

• miR-143 overexpression increased central memory T (Tcm) CD8+ cell differentiation, reduced apoptosis, and boosted pro-inflammatory cytokines.
• miR-143 enhanced HER2-CAR T cell killing of esophageal cancer cells.
• miR-143 targets Glucose transporter 1 (Glut-1), inhibiting glucose uptake and glycolysis to regulate T cell differentiation.
• miR-143 and Tcm cell populations were downregulated in esophageal cancer tissues.
• IDO and kynurenine were identified as upstream regulators, with IDO inhibition increasing miR-143 and Tcm cells.

Conclusions:

• miR-143 enhances anti-tumor T cell effects by promoting memory T cell differentiation and metabolic reprogramming via Glut-1.
• Targeting miR-143 presents a promising strategy for developing novel cancer immunotherapies.
• This study elucidates a novel regulatory pathway involving miR-143, Glut-1, and IDO in T cell immunity and cancer.